news investment opportunities marine natural products
about us
our libraries
partners & research
frequently asked questions
contact us
11-07-2007 Magellan BioScience Group, Inc. and the University of Medicine and Dentistry of New Jersey enter into anti-Leukemia Drug Discovery Collaboration. Read Press Release
7-13-2007 Magellan BioScience Group, Inc. debuts its innovative and interactive forum: marineNaturalproducts.com™ Read Press Release
6-13-2007 Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on identification of novel hits from both marine derivate and natural products. Read Press Release
7-06-2007 Magellan BioScience Group, Inc. awarded SBIR grant for anti-Malarial Drug Discovery Collaboration with University of South Florida. Read Press Release
11-13-2006 Magellan BioScience Closes first Tranche of Financing: Relocates Corporate Offices. Read Press Release
7-18-2006 Bayer CropScience and Magellan BioScience Group Establish Agrochemical Discovery Collaboration Read Press Release
2-17-2006 Fox News Program "The Edge" features story on Magellan BioScience Group, Inc. Watch the Story
1-09-2006 Magellan BioScience Group, Inc. and Memorial Sloan-Kettering Cancer Center Establish Drug Discovery Collaboration. Read Article
9-15-2005 Cyclops Research & Development, Inc. and Magellan BioScience Group, Inc. Announce Cooperative Research and Development Agreement to Discover new Medicines from the Deep Ocean Floor. Read Article
4-01-2005 Magellan BioScience After Drugs from Brittlestar. Read Article
(Ocean News & Technology - March/April)
12-06-2004 Magellan BioScience Licenses Patent from Appalachian State University for Anti-Infective Drug Candidate. Read Article
4-01-2004 Expedition Produces Results for Magellan and Applied Subsea. Read Article
(Ocean News & Technology - March/April)
2-27-2004 Company Dives for Cancer Cures. Read Article
(The Tampa Tribune)
10-04-1999 Incubator Helps Biotech Firms Thrive. Read Article
(The Tampa Tribune)

For more information, call 727-865-1300 or contact us by email.